Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641172-25-012694
Filing Date
2025-05-28
Accepted
2025-05-28 16:15:35
Documents
1
Effectiveness Date
2025-05-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15649
  Complete submission text file 0001641172-25-012694.txt   17095
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-547406 | Film No.: 25995589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)